Secondary Logo

Institutional members access full text with Ovid®

Total Pancreatectomy for Presumed Intraductal Papillary Mucinous Neoplasms

A Multicentric Study of the French Surgical Association (AFC)

Poiraud, Charles, MD*,†; El Amrani, Mehdi, MD*,†; Barbier, Louise, MD, PhD‡,§; Chiche, Laurence, MD, PhD; Mabrut, Jean Yves, MD, PhD||; Bachellier, Philippe, MD, PhD**; Pruvot, François-René, MD, PhD*,†; Delpero, Jean-Robert, MD, PhD††; Tuech, Jean Jacques, MD, PhD‡‡; Adham, Mustapha, MD, PhD§§; Sauvanet, Alain, MD, PhD§; Turrini, Olivier, MD, PhD††; Truant, Stéphanie, MD, PhD*,†

doi: 10.1097/SLA.0000000000002944

Objective: The aim of the current study was to assess the short and long-term outcome of total pancreatectomy (TP) for IPMN based on the largest series to date.

Background: Literature data are scarce regarding TP for IPMN, though increasingly performed in this setting.

Methods: Data of 888 IPMN patients operated between 2004 and 2013 were collected in a multicentric retrospective AFC database. Ninety-three patients (10.5%) who had TP entered this study. Patient demographics, indications, intraoperative data, 3-month morbi-mortality (Clavien), and long-term outcome were analyzed.

Results: Most patients had mixed type IPMN (59%) and underwent upfront (56%) or intraoperatively-decided (33%) TP. Morbidity and mortality rates were 47.3% and 4.3%, respectively, with no lethal hypoglycemia; morbidity was higher for intraoperatively-decided TP. Misdiagnoses were frequent regarding main pancreatic duct involvement (12%), invasiveness (33%), or mural nodules (50%), resulting in 12 TPs (13%) performed for asymptomatic IPMN showing only low/moderate dysplasia (LMD). On histopathological examination, there were 54 (58%) invasive IPMN (mostly pT3/T4 (76%), N+ (60%), R0 (75%)), with a significantly worse 5-year survival (21.2%) compared to noninvasive group (85.7%; P < 0.0001). In the former, 24 (58.5%) developed recurrence showing mostly distant metastasis, within 2 years in 92%.

Conclusion: This large series of TP for IPMN reported acceptable morbi-mortality rates with no long-term death from diabetes-related complication. Morphologic assessment was imperfectly reliable with 13% of TP done for LMD only. More than half of patients were operated at an invasive carcinoma stage with poor outcome. Conversely, long-term survival was excellent after TP for noninvasive IPMN.

*Department of Digestive Surgery, Hôpital Claude Huriez, Lille, France

University of Lille, Lille, France

Department of Digestive Surgery, Hôpital Trousseau, Tours, France

§Department of Digestive Surgery, Hôpital Beaujon, Paris, France

Department of Digestive Surgery, Maison du Haut-Lévêque, Bordeaux, France

||Department of Digestive Surgery, Hôpital de la Croix Rousse, Lyon, France

**Department of Digestive Surgery, Hopital de Hautepierre, Strasbourg, France

††Department of Digestive Surgery, Institut Paoli Calmettes, Marseille, France

‡‡Department of Surgery, Hôpital Charles Nicolle, Rouen, France

§§Department of Digestive Surgery, Hôpital Edouard-Herriot, Lyon, France.

Reprints: Stéphanie Truant, MD, PhD, Service de Chirurgie Digestive et Transplantation, Hôpital HURIEZ, Rue M. Polonovski, CHU, Univ Nord de France, F-59000 Lille, France. E-mail:, Charles Poiraud, MD, Centre Hospitalier Regional Universitaire de Lille, Lille, Nord F-59000, France. E-mail:

The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.